Skip to main content
SpringerLink
Log in

Long-term influence of adjuvant therapy on natural killer cell activity in breast cancer

  • Original Articles
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Summary

Unstimulated IFN- and IL2-stimulated (NK) cell activities were investigated in patients with breast cancer who had received either local radiotherapy alone or adjuvant chemotherapeutic treatment with CMF combined with radiotherapy 12 to 18 months previously. When tested against the primarily NK-sensitive K562 cell line, patients who had received adjuvant chemotherapeutic treatment with CMF were shown to have a significantly decreased unstimulated and IFN-stimulated NK cell activity, as compared to both patients after radiotherapy only (P<0.002) and P<0.005, respectively) and healthy control persons (P<0.05). The former group of patients also had a significantly decreased IFN-stimulated NK cell activity, when tested against the primarily NK-insensitive Chang hepatoma cell line, as compared to patients after radiotherapy only (P<0.005) and healthy controls (P<0.05). Moreover, patients after radiotherapy only proved to have a significantly increased unstimulated (P<0.01) and IFN-stimulated NK cell activity (K562: P<0.05; Chang hepatoma cell line: P<0.05), as compared to healthy control individuals. In contrast, no difference in IL2-stimulated NK cell activity was detected. The investigation for the expression of CD3 and/or Leu 19 antigens as phenotypic markers of cells with non-MHC restricted cytotoxicity showed a significantly lower percentage of cells with the CD3+ phenotype in patients with breast cancer, irrespective of the chosen post-operative treatment, as compared to healthy controls (P<0.01). Finally, patients with breast cancer who had received radiotherapy only had a significant trend towards an increased percentage of CD3+/Leu 19+ PMNC, as compared to both patients after CMF treatment (P<0.05) and healthy controls (P<0.025). We conclude that patients with breast cancer vary on a long-term basis in their NK activity and in the phenotype of their PMNC depending on their post-operative adjuvant management.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

NK:

natural killer cells

IFN:

interferon

IL 2:

interleukin 2

CMF:

cyclophosphamide, methotrexate, fluorouracil

ER:

oestrogen receptor

PMNC:

peripheral blood mononuclear cells

MHC:

major histocompatibility complex

CTL:

cytotoxic T lymphocytes

References

  1. Abruzzo LV, Rowley DA (1983) Homeostasis of the antibody response: Immunoregulation by NK cells. Science 222:581–585

    Google Scholar 

  2. Abruzzo LV, Mullen CA, Rowley DA (1986) Immunoregulation by natural killer cells. Cell Immunol 98:266–278

    Google Scholar 

  3. Berenbaum MC (1974) Effects of cytotoxic drugs and ionizing radiation on immune responses. In: Stoll BA (ed) Host defence in breast cancer. Year Book Medical Publishers, p 147

  4. Blomgren H, Baral E, Edsmyr F, Strender LE, Petrini B, Wasserman J (1980) Natural killer activity in peripheral lymphocyte population following local radiation therapy. Acta Radiol Oncol 19:139

    Google Scholar 

  5. Bonadonna G, Rossi A, Valagussa P (1985) Adjuvant chemotherapy in operable breast cancer: Ten years later. Lancet I:976–977

    Google Scholar 

  6. Borden E (1979) Interferons: rationale for clinical trials in neoplastic disease. Ann Intern med 91:472–479

    Google Scholar 

  7. Cunningham-Rundles S, Fillipa Da, Braun DW, et al. (1981) Natural cytotoxicity of peripheral blood lymphocytes and regional lymph node cells in breast cancer in women. J Natl Cancer Inst 67:585–590

    Google Scholar 

  8. Djeu JY, Heinbaugh JA, Holden HT, Herberman RB (1979) Augmentation of mouse natural killer cell activity by interferon and interferon inducers. J Immunol 122:175–188

    Google Scholar 

  9. Frydecka I, Blok K, Kornafel J, Kuliczkowaski K, Polakowska A (1986) Early effects of radium therapy on natural killer activity in patients with gynaecological malignancies. Folia Haematol 113:499

    Google Scholar 

  10. Grimm EA, Mazumder A, Zhang HZ, Rosenberg SA (1982) Lymphokine-activated killer cell phenomenon: Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes. J Exp Med 155:1823–1841

    Article  CAS  PubMed  Google Scholar 

  11. Hanna N, Burton RC (1981) Definitive evidence that natural killer cells inhibit experimental tumor metastasis in vivo. J Immunol 127:1754–1758

    Google Scholar 

  12. Harris J, Sengar D, Stewart T, Hyslop D (1976) The effect of immunosuppressive chemotherapy on immune function in patients with malignant disease. Cancer 37:1058–1067

    Google Scholar 

  13. Heppner GH, Calabresi P (1976) Selective suppression of humoral immunity by antineoplastic drugs. Annu Rev Pharmacol Toxicol 16:367–375

    Google Scholar 

  14. Herberman RB, Ortaldo JR (1981) Natural killer cells: Their role in defenses against disease. Science 214:24–29

    Google Scholar 

  15. Lanier LL, Le AM, Cwirla S, Federspiel N, Phillips JH (1986) Antigenic, functional, and molecular genetic studies of human natural killer cells and cytotoxic T lymphocytes not restricted by the major histocompatibility complex. Fed Proc 45:2823–2828

    Google Scholar 

  16. Levy S, Herberman R, Maluish A, et al. (1985) Prognostic risk assessment in primary breast cancer by behavioral and immunological parameters. Health Phys 4:99–113

    Google Scholar 

  17. Levy S, Herberman R, Maluish A, et al. (1985) Prognostic risk assessment in primary breast cancer by behavioral and immunological parameters. Health Phys 4:99–113

    Google Scholar 

  18. Levy S, Herberman R, Lippman M, d'Angelo T (1987) Correlation of stress factors with sustained depression of natural killer cell activity and predicted prognosis in patients with breast cancer. J Clin Oncol 5:348–353

    Google Scholar 

  19. Levy S, Herberman R, Lippman M, d'Angelo T (1987) Correlation of stress factors with sustained depression of natural killer cell activity and predicted prognosis in patients with breast cancer. J Clin Oncol 5:348–353

    Google Scholar 

  20. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265–275

    CAS  PubMed  Google Scholar 

  21. Müller C, Kalinowska W, Pohanka E, et al. (1987) Lytic effector cell function following kidney transplantation. Transplant Proc 19:2932–2938

    Google Scholar 

  22. Rosenberg SA, Lotze MT, Muul LM, et al. (1985) Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastasic cancer. N Engl J Med 313:1485–1492

    CAS  PubMed  Google Scholar 

  23. Rosenberg SA, Spiess P, Lafreniere R (1986) New approach to the adoptive immunotherapy of cancer with tumour-infiltrating lymphocytes. Science 233:1318–1321

    Google Scholar 

  24. Schwartz RS, Eisner A, Dameshek W (1959) The effect of 6-mercaptopurine on primary and secondary immune responses. J Clin Invest 38:1394–1403

    Google Scholar 

  25. Spona J, Ulm R, Bieglmayer C, Husslein P (1979) Hormone serum levels and hormone receptor contents of endometria in women with normal menstrual cycles and patients bearing endometrial carcinoma. Gynecol Obstet Invest 10:71–80

    Google Scholar 

  26. Welsh RM (1986) Regulation of virus infections by natural killer cells. Nat Immun Cell Growth Regul 5:169–199

    Google Scholar 

  27. White D, Jones DB, Cooke T, Kirkham N (1982) Natural killer (NK) activity in peripheral blood lymphocytes of patients with benign and malignant breast disease. Br J Cancer 46:611–616

    Google Scholar 

  28. Zielinski CC, Kubista E, Salzer H, et al. (1986) Adjuvant chemotherapy combined with tamoxifen in postmenopausal patients with stage II breast cancer. Lancet II:1164

    Google Scholar 

  29. Zielinski CC, Stuller I, Dorner F, et al. (1986) Impaired primary, but not secondary, immune response in breast cancer patients under adjuvant chemotherapy. Cancer 58:1648–1652

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. II. Dept. of Medicine, Garnisongasse 13, A-1090, Vienna, Austria

    E. Tichatschek, C. C. Zielinski & Ch. Müller

  2. I. Dept of Obstetrics and Gynecology, University Hospital, Austria

    P. Sevelda, E. Kubista, K. Czerwenka & J. Spona

  3. Institute of Immunology, University of Vienna, Austria

    H. Wolf & M. M. Eibl

Authors
  1. E. Tichatschek
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. C. Zielinski
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ch. Müller
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P. Sevelda
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. E. Kubista
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. K. Czerwenka
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. J. Spona
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. H. Wolf
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. M. M. Eibl
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tichatschek, E., Zielinski, C.C., Müller, C. et al. Long-term influence of adjuvant therapy on natural killer cell activity in breast cancer. Cancer Immunol Immunother 27, 278–282 (1988). https://doi.org/10.1007/BF00205452

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00205452

Keywords

Search

Navigation